317 related articles for article (PubMed ID: 8445289)
1. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
Kontessis PS; Jones SL; Barrow SE; Stratton PD; Alessandrini P; De Cosmo S; Ritter JM; Viberti GC
J Lab Clin Med; 1993 Mar; 121(3):415-23. PubMed ID: 8445289
[TBL] [Abstract][Full Text] [Related]
2. Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy.
O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
J Hum Hypertens; 1993 Aug; 7(4):327-32. PubMed ID: 8410923
[TBL] [Abstract][Full Text] [Related]
3. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
[TBL] [Abstract][Full Text] [Related]
4. Improvement of renal function with selective thromboxane antagonism in lupus nephritis.
Pierucci A; Simonetti BM; Pecci G; Mavrikakis G; Feriozzi S; Cinotti GA; Patrignani P; Ciabattoni G; Patrono C
N Engl J Med; 1989 Feb; 320(7):421-5. PubMed ID: 2643773
[TBL] [Abstract][Full Text] [Related]
5. Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetes.
Farker K; Merkel U; Schweer H; Haerting J; Madani SF; Eggers R; Müller UA; Seyberth HW; Hoffmann A
Eur J Clin Pharmacol; 2002 May; 58(2):85-91. PubMed ID: 12012138
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of thromboxane synthesis has no influence on HgCl2-induced acute renal failure in the rat.
Vanholder R; Laekeman G; Herman A; Saragananda B; Waterloos MA; Kesteloot D; Lámeire N
Nephrol Dial Transplant; 1989; 4(7):625-31. PubMed ID: 2510059
[TBL] [Abstract][Full Text] [Related]
7. [Changes in blood pressure, proteinuria and renal hemodynamics in type I diabetes with manifestations of diabetic nephropathy after 2 months of captopril therapy].
Komers R; Malý J; Simková R
Cas Lek Cesk; 1993 Jun; 132(12):359-64. PubMed ID: 8343943
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome.
Zipser RD; Kronborg I; Rector W; Reynolds T; Daskalopoulos G
Gastroenterology; 1984 Dec; 87(6):1228-32. PubMed ID: 6593268
[TBL] [Abstract][Full Text] [Related]
9. Renal haemodynamics, sodium and water reabsorption during continuous intravenous infusion of recombinant interleukin-2.
Geertsen PF; von der Maase H; Olsen NV; Fogh-Andersen N; Nielsen SL; Leyssac PP
Clin Sci (Lond); 1998 Jul; 95(1):73-81. PubMed ID: 9662488
[TBL] [Abstract][Full Text] [Related]
10. Effects of thromboxane synthetase inhibition on immune complex glomerulonephritis.
Longhofer SL; Frisbie DD; Johnson HC; Culham CA; Cooley AJ; Schultz KT; Grauer GF
Am J Vet Res; 1991 Mar; 52(3):480-7. PubMed ID: 1827969
[TBL] [Abstract][Full Text] [Related]
11. Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
Mangino MJ; Brunt EM; Von Doersten P; Anderson CB
J Pharmacol Exp Ther; 1989 Jan; 248(1):23-8. PubMed ID: 2643702
[TBL] [Abstract][Full Text] [Related]
12. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of prostaglandins and renal function after hepatic resection.
Matsumata T; Yamamoto K; Shirabe K; Shimada M; Sugimachi K; Takesue F; Muto Y; Ikeda T
Hepatogastroenterology; 1997; 44(15):774-8. PubMed ID: 9222688
[TBL] [Abstract][Full Text] [Related]
14. Short term effect of an aldose reductase inhibitor on urinary albumin excretion rate (UAER) and glomerular filtration rate (GFR) in type 1 diabetic patients with incipient nephropathy.
Ranganathan S; Krempf M; Feraille E; Charbonnel B
Diabete Metab; 1993; 19(2):257-61. PubMed ID: 8339858
[TBL] [Abstract][Full Text] [Related]
15. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin.
Ciabattoni G; Cinotti GA; Pierucci A; Simonetti BM; Manzi M; Pugliese F; Barsotti P; Pecci G; Taggi F; Patrono C
N Engl J Med; 1984 Feb; 310(5):279-83. PubMed ID: 6361565
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of vasoactive substances in chronic renal failure.
Cantaro S; Milan Manani S; Marcon R; Bonfante L; Masiero M; D'Angelo A; Calò L
Clin Nephrol; 2001 May; 55(5):393-9. PubMed ID: 11393385
[TBL] [Abstract][Full Text] [Related]
17. Increased thromboxane B2 excretion in diabetes mellitus.
Katayama S; Inaba M; Maruno Y; Omoto A; Kawazu S; Ishii J
J Lab Clin Med; 1987 Jun; 109(6):711-7. PubMed ID: 3585144
[TBL] [Abstract][Full Text] [Related]
18. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility of renal function measurements in adult men with diabetic nephropathy: research and clinical implications.
Agarwal R
Am J Nephrol; 2007; 27(1):92-100. PubMed ID: 17284896
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective inhibition of thromboxane synthesis on renal function in humans.
Zipser RD
Am J Physiol; 1985 Jun; 248(6 Pt 2):F753-6. PubMed ID: 3839111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
